An obstetrician risks everything in tense April trailer

The Luca Guadagnino-produced film won Venice's Special Jury Prize.

An obstetrician risks everything in tense April trailer

The U.S. is experiencing an abortion access crisis, but women in this country are far from the only ones being denied their own bodily autonomy. Georgian filmmaker Dea Kulumbegashvili (Beginning) takes on this pressing issue in April, which took home the Special Jury Prize after its Venice Film Festival premiere last year.

Produced by Luca Guadagnino, April follows an obstetrician named Nina (Ia Sukhitashvili) who is accused of malpractice after a baby in her care dies during delivery. “The ensuing investigation threatens to expose Nina’s illegal sideline: offering abortions to local women,” the film’s logline reads. “Nina remains fiercely committed to her patients, but she must walk a razor’s edge in order to survive as a pariah in a world which desperately needs her.”

Set in Kulumbegashvili’s hometown of Lagodekhi, the film took its inspiration from a research trip the director took home while preparing for her first film, Beginning. In an interview with Deadline, she recalled seeing women her age who already had upwards of six children, who were “amazing mothers but when you meet somebody in a village who has eight children and no electricity, washing machine or water, cannot read and write, and barely has enough money for food, you start to ask the question, ‘Was it her choice to have that many children?'” She also lauded Georgia’s doctors who “have so much empathy” and “never really go home because [the country doesn’t] have enough doctors.” 

Kulumbegashvili also knew the film would cause an uproar at home. “There will be a public debate,” she said. “There will be a huge critical response from the government. The church will not like it, and people will need to somehow denounce some people who are in the film. It’s totally fine with me. I understand that things might happen.”

April premieres in select U.S. theaters April 25. 

 
Join the discussion...